ClinicalTrials.gov
ClinicalTrials.gov Menu

Phase 1b/2 Trial Using Lapatinib, Everolimus and Capecitabine for Treatment of HER-2 Positive Breast Cancer With CNS Metastasis

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01783756
Recruitment Status : Active, not recruiting
First Posted : February 5, 2013
Last Update Posted : August 7, 2018
Sponsor:
Information provided by (Responsible Party):
Jonsson Comprehensive Cancer Center

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Active, not recruiting
  Estimated Primary Completion Date : June 28, 2019
  Estimated Study Completion Date : June 28, 2020